Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of composition to the preparation of medicament for treating abnormal proliferation of collagen after peritoneal damage

A collagen and composition technology, applied in the field of umbilical cord mesenchymal stem cells or umbilical cord mesenchymal stem cell exosomes, can solve the problems of inability to treat peritoneum and reduce the rate of deterioration of peritoneal fibrosis

Pending Publication Date: 2019-08-23
傅毓秀
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] So far, there is no clinical medicine that can effectively cure the fibrotic peritoneum. Only drugs such as steroids can be given to patients to suppress peritoneal inflammation. Such drugs must be taken for a long time and are accompanied by considerable side effects However, such drugs can only reduce the rate of deterioration of peritoneal fibrosis, and cannot treat the already fibrotic peritoneum to restore its original state

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of composition to the preparation of medicament for treating abnormal proliferation of collagen after peritoneal damage
  • Application of composition to the preparation of medicament for treating abnormal proliferation of collagen after peritoneal damage
  • Application of composition to the preparation of medicament for treating abnormal proliferation of collagen after peritoneal damage

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0094] Example 1. It was shown by Macroscopic that transplantation of human umbilical cord mesenchymal stem cells can treat peritoneal adhesions and abdominal cocoons in mice with peritoneal fibrosis

[0095] Fixed without perfusion ( figure 2 A-E), after fixation with perfusion ( figure 2 The abdominal wall of each group of rats in a-e) was cut open, and the appearance was observed. The results showed that the peritoneum in the abdominal cavity of the normal group was clear and tightly attached to the viscera, so the surface of the liver and small intestine appeared smooth ( figure 2 A and a). Rats in the PD / MGO group were treated with PD / MGO for three weeks, the peritoneum on the surface of the viscera was clearly visible, the edge of the liver became thick and swollen, and the small intestine became hypertrophic due to food accumulation ( figure 2b and b). Rats in the PD / MGO+solvent group were treated with PD / MGO for three weeks, and only given normal saline the nex...

Embodiment 2

[0096] Example 2. Transplantation of human umbilical cord mesenchymal stem cells can reduce the thickening of parietal peritoneum and visceral peritoneum in mice with peritoneal fibrosis

[0097] The parietal peritoneum ( image 3 A-E), and visceral peritoneum ( image 3 G-K), H&E staining was performed to observe the change of peritoneal thickness. The results showed that in the normal group, no matter the parietal peritoneum on the surface of the rectus abdominis muscle or the visceral peritoneum on the surface of the liver, there was only a thin layer ( image 3 A and G). In PD / MGO group, treated with PD / MGO for three weeks, the peritoneal thickness was significantly thickened ( image 3 B and H). The thickness of the visceral peritoneum and parietal peritoneum in the PD / MGO+vehicle group was significantly higher than that in the PD / MGO group, and they also adhered to each other ( image 3 C and I).

[0098] In the PD / MGO+HUMSCs(LD) group, the peritoneal thickness of ...

Embodiment 3

[0099] Example 3: Transplantation of human umbilical cord mesenchymal stem cells can reduce collagen in the parietal peritoneum and visceral peritoneum of mice with peritoneal fibrosis

[0100] The parietal peritoneum ( Figure 4 A-E), and visceral peritoneum ( Figure 4 G-K), Sirius red staining was performed, and collagen was marked to observe the changes of intraperitoneal collagen. The results showed that there was a small amount of collagen in the parietal peritoneum or visceral peritoneum of the normal group ( Figure 4 A and G). In the PD / MGO group, treated with PD / MGO for three weeks, the thickened intraperitoneum had massive accumulation of collagen ( Figure 4 B and H). The parietal peritoneum and visceral peritoneum in the PD / MGO+solvent group not only became thicker, but also the collagen content in the thickened peritoneum and the collagen between the muscle tissue increased significantly ( Figure 4 C and I). In the PD / MGO+HUMSCs(LD) group, the collagen in ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of a composition to the preparation of a medicament for treating a symptom or disorder of abnormal proliferation of collagens after peritoneal treatment and / or damage to peritoneal covering organs in a subject in need thereof, wherein the composition comprises umbilical cord mesenchymal stem cells. The invention also provides application of a composition to the preparation of a medicament for treating a symptom or disorder of abnormal proliferation of collagens after peritoneal treatment and / or damage to peritoneal covering organs in the subject in need thereof, wherein the composition comprises umbilical cord mesenchymal stem cell exosomes.

Description

technical field [0001] The present invention relates to the use of a composition for preparing a medicine for the treatment of symptoms or diseases of abnormal collagen hyperplasia after peritoneal and / or peritoneal-covered organs are damaged in individuals in need, wherein the composition comprises umbilical cord mesenchymal stem cells Or umbilical cord mesenchymal stem cell exosomes (exsosome). Background technique [0002] The peritoneum is the serous membrane covering the inner surface of the abdominal wall, pelvic wall and the surfaces of the abdominal cavity and pelvic organs. Among them, the peritoneum lining the abdominal wall, pelvic wall and lower surface of the diaphragm is called parietal peritoneum, while The peritoneum covering the visceral surface is called the visceral peritoneum, and the peritoneum has the functions of support, fixation, protection, and defense. According to the extent to which the peritoneum covers the internal organs, the organs in the ab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61P43/00A61P29/00
CPCA61K35/28A61K2300/00
Inventor 傅毓秀
Owner 傅毓秀